{"data":{"id":"us-nd/n.d.-cent.-code-23-23.1-02","jurisdiction":"us-nd","citation":"N.D. Cent. Code § 23-23.1-02","heading":"Disciplinary action for administering or prescribing laetrile subject to finding of harmfulness","body":"No physician may be subject to disciplinary action by the North Dakota board of medicine for prescribing or administering amygdalin to a patient under the physician's care who has requested the substance unless the board, in a hearing conducted pursuant to chapter 28-32, has made a formal finding that the substance is harmful.","path":["Title 23 Health And Safety","Chapter 23-23.1 Laetrile"],"source_url":"https://ndlegis.gov/cencode/t23c23-1.pdf","current_through":"2026-07-31T11:12:02","vintage":"","retrieved_at":"2026-09-02T21:04:14Z","sha256":"4fba3f8a1316121a2c7d589408cf55477804389487e17acce886897d4eeaa83e","source_id":"us-nd","stale":true,"prev":"us-nd/n.d.-cent.-code-23-23.1-01","next":"us-nd/n.d.-cent.-code-23-23.1-03"},"notice":"GroundRules: Original legal text. Not legal advice."}